ARCHIVES

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

This article is from The Cancer Letter archive.

Vol. 16 No. 31 | August 3, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

September 28, 2007

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

Hayloc, Krebs Lead Oncology Nurses

May 16, 1997

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training

November 27, 1998